nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—Malaise—Methylprednisolone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Raltegravir—Vertigo—Triamcinolone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Raltegravir—Vertigo—Methylprednisolone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Raltegravir—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Raltegravir—Neutropenia—Methotrexate—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Raltegravir—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Raltegravir—Cough—Triamcinolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Raltegravir—Hypertension—Triamcinolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Raltegravir—Hypertension—Methylprednisolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Raltegravir—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Raltegravir—Myalgia—Triamcinolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Raltegravir—Arthralgia—Methylprednisolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Raltegravir—Myalgia—Methylprednisolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Raltegravir—Eye disorder—Prednisone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Raltegravir—Anxiety—Methylprednisolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Raltegravir—Infestation NOS—Methotrexate—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Raltegravir—Infestation—Methotrexate—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Raltegravir—Depression—Methotrexate—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Raltegravir—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Raltegravir—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Raltegravir—Discomfort—Triamcinolone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Raltegravir—Discomfort—Methylprednisolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Raltegravir—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Raltegravir—Dry mouth—Triamcinolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Raltegravir—Renal failure—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Raltegravir—Angiopathy—Prednisone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Raltegravir—Confusional state—Methylprednisolone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Raltegravir—Immune system disorder—Prednisone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Raltegravir—Malaise—Betamethasone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Raltegravir—Malaise—Dexamethasone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Raltegravir—Vertigo—Betamethasone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Raltegravir—Vertigo—Dexamethasone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Raltegravir—Infection—Triamcinolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Raltegravir—Infection—Methylprednisolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Raltegravir—Haematuria—Methotrexate—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Raltegravir—Insomnia—Prednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Raltegravir—Alopecia—Prednisone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Raltegravir—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Raltegravir—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Raltegravir—Epistaxis—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Raltegravir—Paraesthesia—Prednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Raltegravir—Mental disorder—Prednisone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Raltegravir—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Raltegravir—Erythema—Prednisone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Raltegravir—Malnutrition—Prednisone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Raltegravir—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Raltegravir—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Raltegravir—Hypertension—Betamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Raltegravir—Hypertension—Dexamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Raltegravir—Myalgia—Betamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Raltegravir—Myalgia—Dexamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Raltegravir—Anxiety—Betamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Raltegravir—Anxiety—Dexamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Raltegravir—Discomfort—Dexamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Raltegravir—Discomfort—Betamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Raltegravir—Pain—Prednisolone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Raltegravir—Hepatitis—Methotrexate—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Raltegravir—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Raltegravir—Urethral disorder—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Raltegravir—Insomnia—Triamcinolone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Raltegravir—Insomnia—Methylprednisolone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Raltegravir—Infection—Dexamethasone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Raltegravir—Infection—Betamethasone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Raltegravir—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Raltegravir—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Raltegravir—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Raltegravir—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Raltegravir—Visual impairment—Methotrexate—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Raltegravir—Anaemia—Prednisone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Raltegravir—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Raltegravir—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Raltegravir—Agitation—Prednisone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Raltegravir—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Raltegravir—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Raltegravir—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Raltegravir—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Raltegravir—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Raltegravir—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Raltegravir—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Raltegravir—Malaise—Prednisone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Raltegravir—Vertigo—Prednisone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Raltegravir—Eye disorder—Methotrexate—psoriatic arthritis	0.001	0.001	CcSEcCtD
Raltegravir—Tinnitus—Methotrexate—psoriatic arthritis	0.000999	0.000999	CcSEcCtD
Raltegravir—Urticaria—Prednisolone—psoriatic arthritis	0.000995	0.000995	CcSEcCtD
Raltegravir—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000994	0.000994	CcSEcCtD
Raltegravir—Fatigue—Triamcinolone—psoriatic arthritis	0.000993	0.000993	CcSEcCtD
Raltegravir—Fatigue—Methylprednisolone—psoriatic arthritis	0.000991	0.000991	CcSEcCtD
Raltegravir—Pain—Triamcinolone—psoriatic arthritis	0.000985	0.000985	CcSEcCtD
Raltegravir—Angiopathy—Methotrexate—psoriatic arthritis	0.000972	0.000972	CcSEcCtD
Raltegravir—Immune system disorder—Methotrexate—psoriatic arthritis	0.000967	0.000967	CcSEcCtD
Raltegravir—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000965	0.000965	CcSEcCtD
Raltegravir—Hypertension—Prednisone—psoriatic arthritis	0.000963	0.000963	CcSEcCtD
Raltegravir—Chills—Methotrexate—psoriatic arthritis	0.000961	0.000961	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000953	0.000953	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000953	0.000953	CcSEcCtD
Raltegravir—Myalgia—Prednisone—psoriatic arthritis	0.00095	0.00095	CcSEcCtD
Raltegravir—Arthralgia—Prednisone—psoriatic arthritis	0.00095	0.00095	CcSEcCtD
Raltegravir—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00095	0.00095	CcSEcCtD
Raltegravir—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000947	0.000947	CcSEcCtD
Raltegravir—Anxiety—Prednisone—psoriatic arthritis	0.000947	0.000947	CcSEcCtD
Raltegravir—Alopecia—Methotrexate—psoriatic arthritis	0.000946	0.000946	CcSEcCtD
Raltegravir—Insomnia—Dexamethasone—psoriatic arthritis	0.000946	0.000946	CcSEcCtD
Raltegravir—Insomnia—Betamethasone—psoriatic arthritis	0.000946	0.000946	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000943	0.000943	CcSEcCtD
Raltegravir—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00094	0.00094	CcSEcCtD
Raltegravir—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000939	0.000939	CcSEcCtD
Raltegravir—Paraesthesia—Betamethasone—psoriatic arthritis	0.000939	0.000939	CcSEcCtD
Raltegravir—Discomfort—Prednisone—psoriatic arthritis	0.000938	0.000938	CcSEcCtD
Raltegravir—Mental disorder—Methotrexate—psoriatic arthritis	0.000938	0.000938	CcSEcCtD
Raltegravir—Erythema—Methotrexate—psoriatic arthritis	0.000932	0.000932	CcSEcCtD
Raltegravir—Malnutrition—Methotrexate—psoriatic arthritis	0.000932	0.000932	CcSEcCtD
Raltegravir—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000923	0.000923	CcSEcCtD
Raltegravir—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00092	0.00092	CcSEcCtD
Raltegravir—Dyspepsia—Betamethasone—psoriatic arthritis	0.00092	0.00092	CcSEcCtD
Raltegravir—Urticaria—Triamcinolone—psoriatic arthritis	0.000915	0.000915	CcSEcCtD
Raltegravir—Urticaria—Methylprednisolone—psoriatic arthritis	0.000913	0.000913	CcSEcCtD
Raltegravir—Dysgeusia—Methotrexate—psoriatic arthritis	0.000913	0.000913	CcSEcCtD
Raltegravir—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000911	0.000911	CcSEcCtD
Raltegravir—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000909	0.000909	CcSEcCtD
Raltegravir—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000909	0.000909	CcSEcCtD
Raltegravir—Decreased appetite—Betamethasone—psoriatic arthritis	0.000909	0.000909	CcSEcCtD
Raltegravir—Infection—Prednisone—psoriatic arthritis	0.000905	0.000905	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000903	0.000903	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000903	0.000903	CcSEcCtD
Raltegravir—Back pain—Methotrexate—psoriatic arthritis	0.000902	0.000902	CcSEcCtD
Raltegravir—Fatigue—Dexamethasone—psoriatic arthritis	0.000901	0.000901	CcSEcCtD
Raltegravir—Fatigue—Betamethasone—psoriatic arthritis	0.000901	0.000901	CcSEcCtD
Raltegravir—Pain—Betamethasone—psoriatic arthritis	0.000894	0.000894	CcSEcCtD
Raltegravir—Pain—Dexamethasone—psoriatic arthritis	0.000894	0.000894	CcSEcCtD
Raltegravir—Nervous system disorder—Prednisone—psoriatic arthritis	0.000893	0.000893	CcSEcCtD
Raltegravir—Skin disorder—Prednisone—psoriatic arthritis	0.000884	0.000884	CcSEcCtD
Raltegravir—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00088	0.00088	CcSEcCtD
Raltegravir—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000865	0.000865	CcSEcCtD
Raltegravir—Anaemia—Methotrexate—psoriatic arthritis	0.000862	0.000862	CcSEcCtD
Raltegravir—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000862	0.000862	CcSEcCtD
Raltegravir—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000862	0.000862	CcSEcCtD
Raltegravir—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000855	0.000855	CcSEcCtD
Raltegravir—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000855	0.000855	CcSEcCtD
Raltegravir—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000849	0.000849	CcSEcCtD
Raltegravir—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000847	0.000847	CcSEcCtD
Raltegravir—Malaise—Methotrexate—psoriatic arthritis	0.000841	0.000841	CcSEcCtD
Raltegravir—Vertigo—Methotrexate—psoriatic arthritis	0.000838	0.000838	CcSEcCtD
Raltegravir—Urticaria—Dexamethasone—psoriatic arthritis	0.000831	0.000831	CcSEcCtD
Raltegravir—Urticaria—Betamethasone—psoriatic arthritis	0.000831	0.000831	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00083	0.00083	CcSEcCtD
Raltegravir—Dizziness—Prednisolone—psoriatic arthritis	0.000829	0.000829	CcSEcCtD
Raltegravir—Asthenia—Triamcinolone—psoriatic arthritis	0.000827	0.000827	CcSEcCtD
Raltegravir—Abdominal pain—Betamethasone—psoriatic arthritis	0.000826	0.000826	CcSEcCtD
Raltegravir—Body temperature increased—Betamethasone—psoriatic arthritis	0.000826	0.000826	CcSEcCtD
Raltegravir—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000826	0.000826	CcSEcCtD
Raltegravir—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000826	0.000826	CcSEcCtD
Raltegravir—Asthenia—Methylprednisolone—psoriatic arthritis	0.000825	0.000825	CcSEcCtD
Raltegravir—Insomnia—Prednisone—psoriatic arthritis	0.000824	0.000824	CcSEcCtD
Raltegravir—Paraesthesia—Prednisone—psoriatic arthritis	0.000818	0.000818	CcSEcCtD
Raltegravir—Pruritus—Triamcinolone—psoriatic arthritis	0.000815	0.000815	CcSEcCtD
Raltegravir—Cough—Methotrexate—psoriatic arthritis	0.000814	0.000814	CcSEcCtD
Raltegravir—Pruritus—Methylprednisolone—psoriatic arthritis	0.000813	0.000813	CcSEcCtD
Raltegravir—Dyspepsia—Prednisone—psoriatic arthritis	0.000801	0.000801	CcSEcCtD
Raltegravir—Chest pain—Methotrexate—psoriatic arthritis	0.000794	0.000794	CcSEcCtD
Raltegravir—Myalgia—Methotrexate—psoriatic arthritis	0.000794	0.000794	CcSEcCtD
Raltegravir—Arthralgia—Methotrexate—psoriatic arthritis	0.000794	0.000794	CcSEcCtD
Raltegravir—Decreased appetite—Prednisone—psoriatic arthritis	0.000791	0.000791	CcSEcCtD
Raltegravir—Rash—Prednisolone—psoriatic arthritis	0.00079	0.00079	CcSEcCtD
Raltegravir—Dermatitis—Prednisolone—psoriatic arthritis	0.000789	0.000789	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000788	0.000788	CcSEcCtD
Raltegravir—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000787	0.000787	CcSEcCtD
Raltegravir—Fatigue—Prednisone—psoriatic arthritis	0.000785	0.000785	CcSEcCtD
Raltegravir—Headache—Prednisolone—psoriatic arthritis	0.000785	0.000785	CcSEcCtD
Raltegravir—Discomfort—Methotrexate—psoriatic arthritis	0.000784	0.000784	CcSEcCtD
Raltegravir—Constipation—Prednisone—psoriatic arthritis	0.000779	0.000779	CcSEcCtD
Raltegravir—Confusional state—Methotrexate—psoriatic arthritis	0.000767	0.000767	CcSEcCtD
Raltegravir—Dizziness—Triamcinolone—psoriatic arthritis	0.000762	0.000762	CcSEcCtD
Raltegravir—Dizziness—Methylprednisolone—psoriatic arthritis	0.00076	0.00076	CcSEcCtD
Raltegravir—Infection—Methotrexate—psoriatic arthritis	0.000756	0.000756	CcSEcCtD
Raltegravir—Feeling abnormal—Prednisone—psoriatic arthritis	0.00075	0.00075	CcSEcCtD
Raltegravir—Asthenia—Dexamethasone—psoriatic arthritis	0.00075	0.00075	CcSEcCtD
Raltegravir—Asthenia—Betamethasone—psoriatic arthritis	0.00075	0.00075	CcSEcCtD
Raltegravir—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000746	0.000746	CcSEcCtD
Raltegravir—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000745	0.000745	CcSEcCtD
Raltegravir—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000745	0.000745	CcSEcCtD
Raltegravir—Nausea—Prednisolone—psoriatic arthritis	0.000744	0.000744	CcSEcCtD
Raltegravir—Pruritus—Dexamethasone—psoriatic arthritis	0.00074	0.00074	CcSEcCtD
Raltegravir—Pruritus—Betamethasone—psoriatic arthritis	0.00074	0.00074	CcSEcCtD
Raltegravir—Skin disorder—Methotrexate—psoriatic arthritis	0.000739	0.000739	CcSEcCtD
Raltegravir—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000736	0.000736	CcSEcCtD
Raltegravir—Vomiting—Triamcinolone—psoriatic arthritis	0.000733	0.000733	CcSEcCtD
Raltegravir—Vomiting—Methylprednisolone—psoriatic arthritis	0.000731	0.000731	CcSEcCtD
Raltegravir—Rash—Triamcinolone—psoriatic arthritis	0.000727	0.000727	CcSEcCtD
Raltegravir—Dermatitis—Triamcinolone—psoriatic arthritis	0.000726	0.000726	CcSEcCtD
Raltegravir—Rash—Methylprednisolone—psoriatic arthritis	0.000725	0.000725	CcSEcCtD
Raltegravir—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000724	0.000724	CcSEcCtD
Raltegravir—Urticaria—Prednisone—psoriatic arthritis	0.000723	0.000723	CcSEcCtD
Raltegravir—Headache—Triamcinolone—psoriatic arthritis	0.000722	0.000722	CcSEcCtD
Raltegravir—Headache—Methylprednisolone—psoriatic arthritis	0.00072	0.00072	CcSEcCtD
Raltegravir—Body temperature increased—Prednisone—psoriatic arthritis	0.00072	0.00072	CcSEcCtD
Raltegravir—Abdominal pain—Prednisone—psoriatic arthritis	0.00072	0.00072	CcSEcCtD
Raltegravir—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000715	0.000715	CcSEcCtD
Raltegravir—Diarrhoea—Betamethasone—psoriatic arthritis	0.000715	0.000715	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000693	0.000693	CcSEcCtD
Raltegravir—Dizziness—Dexamethasone—psoriatic arthritis	0.000691	0.000691	CcSEcCtD
Raltegravir—Dizziness—Betamethasone—psoriatic arthritis	0.000691	0.000691	CcSEcCtD
Raltegravir—Insomnia—Methotrexate—psoriatic arthritis	0.000688	0.000688	CcSEcCtD
Raltegravir—Nausea—Triamcinolone—psoriatic arthritis	0.000684	0.000684	CcSEcCtD
Raltegravir—Paraesthesia—Methotrexate—psoriatic arthritis	0.000683	0.000683	CcSEcCtD
Raltegravir—Nausea—Methylprednisolone—psoriatic arthritis	0.000683	0.000683	CcSEcCtD
Raltegravir—Somnolence—Methotrexate—psoriatic arthritis	0.000676	0.000676	CcSEcCtD
Raltegravir—Hypersensitivity—Prednisone—psoriatic arthritis	0.000671	0.000671	CcSEcCtD
Raltegravir—Dyspepsia—Methotrexate—psoriatic arthritis	0.00067	0.00067	CcSEcCtD
Raltegravir—Vomiting—Betamethasone—psoriatic arthritis	0.000665	0.000665	CcSEcCtD
Raltegravir—Vomiting—Dexamethasone—psoriatic arthritis	0.000665	0.000665	CcSEcCtD
Raltegravir—Decreased appetite—Methotrexate—psoriatic arthritis	0.000661	0.000661	CcSEcCtD
Raltegravir—Rash—Betamethasone—psoriatic arthritis	0.000659	0.000659	CcSEcCtD
Raltegravir—Rash—Dexamethasone—psoriatic arthritis	0.000659	0.000659	CcSEcCtD
Raltegravir—Dermatitis—Dexamethasone—psoriatic arthritis	0.000659	0.000659	CcSEcCtD
Raltegravir—Dermatitis—Betamethasone—psoriatic arthritis	0.000659	0.000659	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000657	0.000657	CcSEcCtD
Raltegravir—Fatigue—Methotrexate—psoriatic arthritis	0.000656	0.000656	CcSEcCtD
Raltegravir—Headache—Betamethasone—psoriatic arthritis	0.000655	0.000655	CcSEcCtD
Raltegravir—Headache—Dexamethasone—psoriatic arthritis	0.000655	0.000655	CcSEcCtD
Raltegravir—Asthenia—Prednisone—psoriatic arthritis	0.000653	0.000653	CcSEcCtD
Raltegravir—Pain—Methotrexate—psoriatic arthritis	0.000651	0.000651	CcSEcCtD
Raltegravir—Pruritus—Prednisone—psoriatic arthritis	0.000644	0.000644	CcSEcCtD
Raltegravir—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000627	0.000627	CcSEcCtD
Raltegravir—Diarrhoea—Prednisone—psoriatic arthritis	0.000623	0.000623	CcSEcCtD
Raltegravir—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000622	0.000622	CcSEcCtD
Raltegravir—Nausea—Dexamethasone—psoriatic arthritis	0.000621	0.000621	CcSEcCtD
Raltegravir—Nausea—Betamethasone—psoriatic arthritis	0.000621	0.000621	CcSEcCtD
Raltegravir—Urticaria—Methotrexate—psoriatic arthritis	0.000605	0.000605	CcSEcCtD
Raltegravir—Dizziness—Prednisone—psoriatic arthritis	0.000602	0.000602	CcSEcCtD
Raltegravir—Abdominal pain—Methotrexate—psoriatic arthritis	0.000602	0.000602	CcSEcCtD
Raltegravir—Body temperature increased—Methotrexate—psoriatic arthritis	0.000602	0.000602	CcSEcCtD
Raltegravir—Vomiting—Prednisone—psoriatic arthritis	0.000579	0.000579	CcSEcCtD
Raltegravir—Rash—Prednisone—psoriatic arthritis	0.000574	0.000574	CcSEcCtD
Raltegravir—Dermatitis—Prednisone—psoriatic arthritis	0.000574	0.000574	CcSEcCtD
Raltegravir—Headache—Prednisone—psoriatic arthritis	0.00057	0.00057	CcSEcCtD
Raltegravir—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000561	0.000561	CcSEcCtD
Raltegravir—Asthenia—Methotrexate—psoriatic arthritis	0.000546	0.000546	CcSEcCtD
Raltegravir—Nausea—Prednisone—psoriatic arthritis	0.000541	0.000541	CcSEcCtD
Raltegravir—Pruritus—Methotrexate—psoriatic arthritis	0.000538	0.000538	CcSEcCtD
Raltegravir—Diarrhoea—Methotrexate—psoriatic arthritis	0.000521	0.000521	CcSEcCtD
Raltegravir—Dizziness—Methotrexate—psoriatic arthritis	0.000503	0.000503	CcSEcCtD
Raltegravir—Vomiting—Methotrexate—psoriatic arthritis	0.000484	0.000484	CcSEcCtD
Raltegravir—Rash—Methotrexate—psoriatic arthritis	0.00048	0.00048	CcSEcCtD
Raltegravir—Dermatitis—Methotrexate—psoriatic arthritis	0.000479	0.000479	CcSEcCtD
Raltegravir—Headache—Methotrexate—psoriatic arthritis	0.000477	0.000477	CcSEcCtD
Raltegravir—Nausea—Methotrexate—psoriatic arthritis	0.000452	0.000452	CcSEcCtD
